Quantcast

FamilyCord and Hoag Hospital Team Up for Cord Blood Storage

December 21, 2010

LOS ANGELES, Dec. 21, 2010 /PRNewswire/ — FamilyCord and Hoag Hospital announced a transfer agreement establishing FamilyCord as the cord blood storage provider for the Hoag Cancer Center and Cell Biology Lab.

FamilyCord has successfully relocated all of Hoag Hospital’s existing stored cord blood units to its state-of-the-art facility in Los Angeles and will provide ongoing storage to the patients interested in preserving their cord blood stem cells.

“It has been a pleasure working with the Hoag team,” said Richard Jennings, President of FamilyCord. “We are very pleased to be working so closely with such an outstanding medical facility.”

FamilyCord recently unveiled a new collection kit as part of their mission to redefine and improve the scientific standards for the cord blood banking industry. The new kit offers multiple benefits over “card board” kits, including temperature stabilization that provides up to ten hours of protection (versus 30 minutes with standard kits), and conical tube protectors to provide more crush protection and leak prevention.

“As more and more families take advantage of cord blood banking, it is imperative that we as an industry do everything we can to insure that their investment is protected,” says Jennings.

FamilyCord’s new kit also utilizes liquid CPD anticoagulant in the collection bag, which provides up to 58% more CD34+ stem cells than using the dry heparin (American Society of Hematology, 2009).

Media Contact: Scott Brown (310) 496-5681

Founded in 1997, FamilyCord is a subsidiary of the California Cryobank and is registered with the FDA and accredited by the AABB (American Association of Blood Banks). For more information, call 888-828-2673 or visit www.familycord.com.

Hoag Hospital is a not-for-profit, faith-based hospital established in 1952 to provide the highest quality health care services to the communities we serve. For more information please visit www.hoag.org.

SOURCE FamilyCord


Source: newswire



comments powered by Disqus